person

Igor S.

Country
France
Department
Unité Neurovasculaire

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
228
Sites with multiple studies

Has run more than one trial at 228 of 779 partner sites.

Specializations

Acute Stroke Management

The investigator specializes in treating acute ischemic stroke with particular emphasis on cases involving large ischemic core. Their research encompasses innovative therapeutic approaches including endovascular therapy and novel pharmaceutical interventions.

  • Large core ischemic stroke treatment
  • Regenerative stem cell therapy
  • Novel pharmaceutical compounds

Current focus includes evaluating advanced treatment options for improving functional outcomes in stroke patients.

Hemorrhagic Stroke Research

The investigator conducts research in intracerebral hemorrhage management, with particular attention to anticoagulation strategies and hemostatic interventions. Their work includes studying tranexamic acid applications in acute hemorrhagic events.

  • Anticoagulation management
  • Hemorrhage control strategies
  • Post-hemorrhagic treatment protocols

Research extends to investigating iron chelation therapy for preventing secondary degeneration after stroke.

Stroke Prevention

The investigator focuses on secondary stroke prevention, particularly in patients with transient ischemic attacks. Their research includes evaluating novel anticoagulants and antiplatelet agents for preventing recurrent cerebrovascular events.

  • Non-cardioembolic stroke prevention
  • Antiplatelet therapy optimization
  • Risk reduction strategies

Current investigations include innovative pharmacological approaches for stroke prevention in high-risk populations.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.